β³ Fetching live dividend data...
Home βΊ Calculator βΊ RVVQF Dividend Calculator 2026
RavenQuest BioMed Inc. Β· OTC
Price: $0.00 Β· Annual div: $2.00/share Β· Frequency: quarterly Β· Payout ratio: 50% Β· Ex-div: TBD
Click to apply scenario to the calculator
Year your monthly dividend income covers each expense (based on current settings)
$10,000 in RVVQF β $1.0240512011520145e+51M in 10 years Β· $85,337,173,410,134,160,000,000,000,000,000,000,000,000,000,000,000,000,000.00/month
RavenQuest BioMed Inc., a cannabis company, focuses on the cannabis production, management services and consulting, and specialized research and development activities. The company operates in two segments, Consulting Business, and Cultivation and Sale of Medical Cannabis. It offers its products under the Lore Cannabis and Bloomera brand names. The company was formerly known as Ravencrest Resources Inc. and changed its name to RavenQuest BioMed Inc. in September 2017. RavenQuest BioMed Inc. was incorporated in 1987 and is based in Vancouver, Canada.
This calculation uses the DividendFlow Engine v6.0. Data is verified daily against SEC filings and FMP real-time feeds to ensure projection accuracy.
We'll send you a full breakdown of your projections, DRIP tips, and how to enable dividend reinvestment with your broker.
Free forever. No spam. Unsubscribe anytime.
Ready to invest? Open RVVQF position with:
Real after-tax yield depends on where you live and how you hold RVVQF.
| Account/Country | Tax Rate | After-tax Yield | Real Yield | $10K Annual Income |
|---|---|---|---|---|
| πΊπΈ Roth IRA / 401k | 0% | 20000000.00% | 19999997.20% | $2,000,000,000 / yr |
| πΊπΈ US Taxable (15%) β | 15% | 17000000.00% | 16999997.20% | $1,700,000,000 / yr |
| πΊπΈ US Taxable (20%) | 20% | 16000000.00% | 15999997.20% | $1,600,000,000 / yr |
| π¬π§ UK ISA | 0% | 20000000.00% | 19999997.20% | $2,000,000,000 / yr |
| π¬π§ UK Taxable | 8.75% | 18250000.00% | 18249997.20% | $1,825,000,000 / yr |
| π¨π¦ TFSA | 0% | 20000000.00% | 19999997.20% | $2,000,000,000 / yr |
| π¨π¦ CA Taxable | 25% | 15000000.00% | 14999997.20% | $1,500,000,000 / yr |
| π¦πΊ Super (pension) | 15% | 17000000.00% | 16999997.20% | $1,700,000,000 / yr |
| π¦πΊ AU Taxable | 30% | 14000000.00% | 13999997.20% | $1,400,000,000 / yr |
| π©πͺ DE Taxable | 26.375% | 14725000.00% | 14724997.20% | $1,472,500,000 / yr |
| π«π· FR Taxable | 30% | 14000000.00% | 13999997.20% | $1,400,000,000 / yr |
Real yield = after-tax yield minus US CPI of 2.8%. 12-month CPI (US BLS via FMP economic-indicators). Click any row to select. US withholding tax (30%, reducible by treaty) applies to non-US residents holding US stocks in taxable accounts.
12-month CPI (US BLS via FMP economic-indicators).
Based on current dividend of $2.00/share/yr Β· πΊπΈ US Taxable (15%) Β· static projection (no growth assumed).
RVVQF pays quarterly β 4 times per year. Next ex-div: TBD.
How RVVQF compares to typical Healthcare averages.
Benchmarks: S&P 500 sector averages (2024β2026). Sources: Morningstar, Bloomberg, NAREIT. 5Y CAGR for RVVQF sourced from FMP /financial-growth endpoint β real data, not estimates.
Altman Z-Score predicts bankruptcy risk. Piotroski F-Score measures financial strength across 9 criteria. High scores β lower dividend cut risk. Data via FMP financial statements.
Dividend yields, payout ratios, and financial metrics are sourced from Financial Modeling Prep (FMP) and cross-referenced with SEC EDGAR filings. Data is cached and updated every 24 hours via our nightly refresh. DRIP projections are forward-looking estimates, not guarantees.
Educational purposes only. Not financial advice. DividendFlow is not a registered investment advisor. Projections generated by the RVVQF dividend calculator are estimates based on historical data and user inputs. Actual future returns, stock prices, and dividend payments will vary. Dividends can be cut or suspended at any time. All investments carry risk, including the loss of principal. Please consult a qualified financial professional before making any investment decisions. Full disclaimer β